Half of Crohn's disease patients develop stenosis around 20 years after the disease onset. For a long time, surgery has been the only therapeutic approach for strictures. The introduction of anti-TNFα could be revolutionary in the management of these patients due to their potential role in stenoses' treatment. The aim of our work was to summarize efficacy data of anti-TNFα drugs in stricturing CD patients.
Efficacy of anti-TNFα drugs in patients with stricturing Crohn's disease / D'Amico, Ferdinando; Pugliese, Nicola; Peyrin-Biroulet, Laurent; Danese, Silvio. - In: EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY. - ISSN 1747-4124. - 14:5(2020), pp. 347-353-353. [10.1080/17474124.2020.1759417]
Efficacy of anti-TNFα drugs in patients with stricturing Crohn's disease
Danese, Silvio
2020-01-01
Abstract
Half of Crohn's disease patients develop stenosis around 20 years after the disease onset. For a long time, surgery has been the only therapeutic approach for strictures. The introduction of anti-TNFα could be revolutionary in the management of these patients due to their potential role in stenoses' treatment. The aim of our work was to summarize efficacy data of anti-TNFα drugs in stricturing CD patients.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
